KING OF PRUSSIA, Pa., Dec. 9 /PRNewswire/ -- Cytokine PharmaSciences, Inc. today announced the promotion of Vidal F. de la Cruz, Ph.D. to the position of Vice President, Business Development. Dr. de la Cruz joined the Company in 2001 as Director of Preclinical Development and assumed additional responsibilities for business development in 2003. He received his B.S. in biology from Fairleigh Dickinson University and his Ph.D. in cell and molecular biology from UCLA. Dr. de la Cruz also did post-doctoral work at the NIH before moving into the biotech industry in 1988. "This is a well deserved promotion," stated Denny Willson, President and CEO of Cytokine PharmaSciences. "Vidal has made an important contribution to our business over the past three years. I look forward to what he can accomplish in his new role as Vice President of Business Development." Cytokine PharmaSciences is a biopharmaceutical company located in King of Prussia, Pennsylvania (near Philadelphia). The company licenses technologies from academia and other sources, develops products from those technologies and outlicenses the products to third parties for marketing. For more information, go to http://www.cytokinepharmasciences.com.
SOURCE Cytokine PharmaSciences, Inc.